ALNYLAM PHARMACEUTICALS, INC. Income Taxes Receivable, Current
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Income Taxes Receivable, Current of $0 as of 2011-12-31, per its 10-K filed 2012-02-13.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2012-02-13
- 2011-12-31: Income Taxes Receivable, Current $0.00.
- 2011-09-30: Income Taxes Receivable, Current $0.00.
- 2011-06-30: Income Taxes Receivable, Current $0.00.
- 2011-03-31: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-02-13 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-03 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-03 |
| 2011-03-31 | $0.00 10-Q · filed 2011-05-05 |
| 2010-12-31 | $10.67M 10-K · filed 2012-02-13 |
| 2009-12-31 | $0.00 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |